mitoxantrone has been researched along with Cirrhosis in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Age is a known susceptibility factor for the cardiotoxicity of several anticancer drugs, including mitoxantrone (MTX)." | 7.81 | The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. ( Bastos, Mde L; Carvalho, F; Costa, VM; Dores-Sousa, JL; Duarte, JA; Seabra, V, 2015) |
| "A 44-year-old man who had achieved a complete remission of malignant peritoneal mesothelioma after the intraperitoneal administration of 25 mg/m2 mitoxantrone presented with clinical and radiological signs of intestinal obstruction suggestive of recurrent disease at about 2 years following the initial treatment." | 7.68 | Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone. ( Gallee, MP; Kroon, BB; Rodenhuis, S; Taal, BG; Vlasveld, LT, 1992) |
| "Age is a known susceptibility factor for the cardiotoxicity of several anticancer drugs, including mitoxantrone (MTX)." | 3.81 | The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. ( Bastos, Mde L; Carvalho, F; Costa, VM; Dores-Sousa, JL; Duarte, JA; Seabra, V, 2015) |
| "A 44-year-old man who had achieved a complete remission of malignant peritoneal mesothelioma after the intraperitoneal administration of 25 mg/m2 mitoxantrone presented with clinical and radiological signs of intestinal obstruction suggestive of recurrent disease at about 2 years following the initial treatment." | 3.68 | Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone. ( Gallee, MP; Kroon, BB; Rodenhuis, S; Taal, BG; Vlasveld, LT, 1992) |
| "Mitoxantrone is a new antineoplastic that differs from bleomycin in that it binds to membranes." | 1.29 | Comparison of mitoxantrone and tetracycline as pleural sclerosing agents in rabbits. ( Despars, JA; Gruer, SE; Light, RW; Sassoon, C; Vargas, FS; Wang, NS, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dores-Sousa, JL | 1 |
| Duarte, JA | 1 |
| Seabra, V | 1 |
| Bastos, Mde L | 1 |
| Carvalho, F | 1 |
| Costa, VM | 1 |
| Toledano, A | 1 |
| Garaud, P | 1 |
| Serin, D | 1 |
| Fourquet, A | 1 |
| Bosset, JF | 1 |
| Miny-Buffet, J | 1 |
| Favre, A | 1 |
| Azria, D | 1 |
| Body, G | 1 |
| Le Floch, O | 1 |
| Calais, G | 1 |
| Light, RW | 1 |
| Wang, NS | 1 |
| Despars, JA | 1 |
| Gruer, SE | 1 |
| Sassoon, C | 1 |
| Vargas, FS | 1 |
| Vlasveld, LT | 1 |
| Taal, BG | 1 |
| Kroon, BB | 1 |
| Gallee, MP | 1 |
| Rodenhuis, S | 1 |
1 trial available for mitoxantrone and Cirrhosis
| Article | Year |
|---|---|
[Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conservative surgery enhances late toxicities].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemo | 2006 |
3 other studies available for mitoxantrone and Cirrhosis
| Article | Year |
|---|---|
The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
Topics: Age Factors; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Biomarkers; Body Weight; C | 2015 |
Comparison of mitoxantrone and tetracycline as pleural sclerosing agents in rabbits.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Fibrosis; Lethal Dose 50; Male; Mi | 1996 |
Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone.
Topics: Adult; Biopsy; Fibrosis; Humans; Injections, Intraperitoneal; Intestinal Obstruction; Jejunal Diseas | 1992 |